Nystatin topical preparations are indicated in the treatment of cutaneous or
mucocutaneous mycotic infections caused by Candida albicans and other
susceptible Candida species.
These preparations are not indicated for systemic, oral, intravaginal or
DOSAGE AND ADMINISTRATION
Very moist lesions are best treated with the topical dusting powder.
MYCOSTATIN (nystatin) ® Cream
Adults and Pediatric Patients (Neonates and Older): Apply liberally
to affected areas twice daily or as indicated until healing is complete.
MYCOSTATIN (nystatin) ® Topical Powder
Adults and Pediatric Patients (Neonates and Older): Apply to candidal
lesions two or three times daily until healing is complete. For fungal infection
of the feet caused by Candida species, the powder should be dusted on the feet,
as well as, in all foot wear.
MYCOSTATIN® Cream: 100,000 units nystatin per gram in an aqueous,
perfumed vanishing cream base, in 30 g (NDC 0003-0579-31) tubes.
MYCOSTATIN® Topical Powder: 100,000 units nystatin per gram in 15
g (NDC 0003-0593-20) plastic squeeze bottles.
MYCOSTATIN® (Nystatin) is also available as vaginal tablets and
in oral formulations (pastilles, suspension, tablets). See package inserts
for complete prescribing information.
MYCOSTATIN (nystatin) ® Cream: Store at room temperature, avoid freezing.
MYCOSTATIN (nystatin) ® Topical Powder: Store at room temperature, avoid excessive
heat (40° C/104° F). Keep tightly closed.
Westwood-Squibb Pharmaceuticals, Inc., A Bristol-Myers Squibb Company, Princeton,
NJ 08543 USA.